Breast cancer-associated fibroblasts: their roles in tumor initiation, progression and clinical applications

Front Med. 2016 Mar;10(1):33-40. doi: 10.1007/s11684-016-0431-5. Epub 2016 Jan 20.

Abstract

Breast cancer is the most common malignant tumor in women, and the incidence of this disease has increased in recent years because of changes in diet, living environment, gestational age, and other unknown factors. Previous studies focused on cancer cells, but an increasing number of recent studies have analyzed the contribution of cancer microenvironment to the initiation and progression of breast cancer. Cancer-associated fibroblasts (CAFs), the most abundant cells in tumor stroma, secrete various active biomolecules, including extracellular matrix components, growth factors, cytokines, proteases, and hormones. CAFs not only facilitate the initiation, growth, angiogenesis, invasion, and metastasis of cancer but also serve as biomarkers in the clinical diagnosis, therapy, and prognosis of breast cancer. In this article, we reviewed the literature and summarized the research findings on CAFs in breast cancer.

Keywords: breast cancer; cancer-associated fibroblast; prognosis; progression.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Breast Neoplasms / diagnosis
  • Breast Neoplasms / etiology
  • Breast Neoplasms / pathology
  • Breast Neoplasms / physiopathology*
  • Cancer-Associated Fibroblasts / physiology*
  • Female
  • Humans
  • Neoplasm Invasiveness
  • Neovascularization, Pathologic / physiopathology
  • Prognosis